{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:42:34Z","timestamp":1789400554419,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-141","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T22:14:18Z","timestamp":1373494458000},"source":"Crossref","is-referenced-by-count":12,"title":["Life-threatening gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Shintaro","family":"Fujihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"569_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jnci\/djr511","volume":"104","author":"E Tim","year":"2012","unstructured":"Tim E, Sternberg CN, et al: Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst. 2012, 104: 93-113. 10.1093\/jnci\/djr511.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"569_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1200\/JCO.2004.08.185","volume":"22","author":"MB Atkins","year":"2004","unstructured":"Atkins MB, Hidalgo M, Stadler WM, et al: Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. J Clin Oncol. 2004, 22 (5): 909-918. 10.1200\/JCO.2004.08.185.","journal-title":"J Clin Oncol"},{"issue":"22","key":"569_CR3","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa066838","volume":"356","author":"G Hudes","year":"2007","unstructured":"Hudes G, Carducci M, Tomczak P, et al: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007, 356 (22): 2271-10.1056\/NEJMoa066838.","journal-title":"N Engl J Med"},{"key":"569_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","volume":"103","author":"T Schmelzle","year":"2000","unstructured":"Schmelzle T, Hall MN: TOR, a central controller of cell growth. Cell. 2000, 103: 253-262. 10.1016\/S0092-8674(00)00117-3.","journal-title":"Cell"},{"key":"569_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","volume":"24","author":"DC Fingar","year":"2004","unstructured":"Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J: mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation factor 4E. Mol Cell Biol. 2004, 24: 200-216. 10.1128\/MCB.24.1.200-216.2004.","journal-title":"Mol Cell Biol"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","volume":"22","author":"CC Hudson","year":"2002","unstructured":"Hudson CC, Liu M, Chiang GG, et al: Regulation of hypoxia-inducible factor 1\u03b1 expression and function by the mammalian target of rapamycin. Mol Cell Biol. 2002, 22: 7004-7014. 10.1128\/MCB.22.20.7004-7014.2002.","journal-title":"Mol Cell Biol"},{"key":"569_CR7","first-page":"4641","volume":"9","author":"AJ Pantuck","year":"2003","unstructured":"Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA: Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res. 2003, 9: 4641-4652.","journal-title":"Clin Cancer Res"},{"key":"569_CR8","unstructured":"EU SmPC Avastin. \n                    http:\/\/www.emea.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000582\/human_med_000663.jsp&mid=WC0b01ac058001d124\n                    \n                  . Accessed July 12, 2013"},{"issue":"1","key":"569_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0016-5085(95)90018-7","volume":"108","author":"JL Payen","year":"1995","unstructured":"Payen JL, Cal\u00e8s P, Voigt JJ, et al: Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995, 108 (1): 138-144. 10.1016\/0016-5085(95)90018-7.","journal-title":"Gastroenterology"},{"issue":"5","key":"569_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jjco\/hys032","volume":"42","author":"A Ehab Saad","year":"2012","unstructured":"Ehab Saad A, Fadi M, Arafat T: Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review. Jpn J Clin Oncol. 2012, 42 (5): 447-450. 10.1093\/jjco\/hys032.","journal-title":"Jpn J Clin Oncol"},{"key":"569_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1440-1746.2011.06873.x","volume":"27","author":"YW Kim","year":"2012","unstructured":"Kim YW, Lee WH, Choi SM, et al: DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway. J Gastroenterol Hepatol. 2012, 27: 397-405. 10.1111\/j.1440-1746.2011.06873.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/00004836-199210000-00019","volume":"15","author":"CJ Gostout","year":"1992","unstructured":"Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R: The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992, 15: 256-263. 10.1097\/00004836-199210000-00019.","journal-title":"J Clin Gastroenterol"},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1572-0241.2006.00370.x","volume":"101","author":"V Kwan","year":"2006","unstructured":"Kwan V, Bourke MJ, Williams SJ, et al: Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol. 2006, 101: 58-63. 10.1111\/j.1572-0241.2006.00370.x.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-141\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:02:03Z","timestamp":1548216123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-141","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]},"article-number":"141"}}